Nijkamp FP - Search Results

1

Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome.

Rijnierse A, Nijkamp FP, Kraneveld AD. Rijnierse A, et al. Among authors: nijkamp fp. Pharmacol Ther. 2007 Nov;116(2):207-35. doi: 10.1016/j.pharmthera.2007.06.008. Epub 2007 Jul 18. Pharmacol Ther. 2007. PMID: 17719089 Review.

2

Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction.

Rijnierse A, Koster AS, Nijkamp FP, Kraneveld AD. Rijnierse A, et al. Among authors: nijkamp fp. J Immunol. 2006 Apr 1;176(7):4375-84. doi: 10.4049/jimmunol.176.7.4375. J Immunol. 2006. PMID: 16547276

3

TNF-alpha is crucial for the development of mast cell-dependent colitis in mice.

Rijnierse A, Koster AS, Nijkamp FP, Kraneveld AD. Rijnierse A, et al. Among authors: nijkamp fp. Am J Physiol Gastrointest Liver Physiol. 2006 Nov;291(5):G969-76. doi: 10.1152/ajpgi.00146.2006. Epub 2006 Jun 22. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16798721 Free article.

4

Beneficial effect of tachykinin NK1 receptor antagonism in the development of hapten-induced colitis in mice.

Rijnierse A, van Zijl KM, Koster AS, Nijkamp FP, Kraneveld AD. Rijnierse A, et al. Among authors: nijkamp fp. Eur J Pharmacol. 2006 Oct 24;548(1-3):150-7. doi: 10.1016/j.ejphar.2006.07.010. Epub 2006 Jul 25. Eur J Pharmacol. 2006. PMID: 16949572

5

Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.

Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J. Kraneveld AD, et al. Among authors: nijkamp fp. Eur J Pharmacol. 2008 May 13;585(2-3):361-74. doi: 10.1016/j.ejphar.2008.02.095. Epub 2008 Mar 18. Eur J Pharmacol. 2008. PMID: 18417115 Review.

6

Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases.

Rijnierse A, Redegeld FA, Blokhuis BR, Van der Heijden MW, Te Velde AA, Pronk I, Hommes DW, Nijkamp FP, Koster AS, Kraneveld AD. Rijnierse A, et al. Among authors: nijkamp fp. J Immunol. 2010 Jul 1;185(1):653-9. doi: 10.4049/jimmunol.0901129. Epub 2010 May 26. J Immunol. 2010. PMID: 20505143 Free article.

7

Excitatory non-adrenergic-non-cholinergic neuropeptides: key players in asthma.

Kraneveld AD, James DE, de Vries A, Nijkamp FP. Kraneveld AD, et al. Among authors: nijkamp fp. Eur J Pharmacol. 2000 Sep 29;405(1-3):113-29. doi: 10.1016/s0014-2999(00)00546-x. Eur J Pharmacol. 2000. PMID: 11033319 Review.

8

Mast cell-derived TNF-alpha primes sensory nerve endings in a pulmonary hypersensitivity reaction.

van Houwelingen AH, Kool M, de Jager SC, Redegeld FA, van Heuven-Nolsen D, Kraneveld AD, Nijkamp FP. van Houwelingen AH, et al. Among authors: nijkamp fp. J Immunol. 2002 May 15;168(10):5297-302. doi: 10.4049/jimmunol.168.10.5297. J Immunol. 2002. PMID: 11994487

9

Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses.

Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, Kraneveld AD, Van Loveren H, Roholl P, Saito T, Verbeek JS, Claassens J, Koster AS, Nijkamp FP. Redegeld FA, et al. Among authors: nijkamp fp. Nat Med. 2002 Jul;8(7):694-701. doi: 10.1038/nm722. Epub 2002 Jun 17. Nat Med. 2002. PMID: 12068287

10

Key role for mast cells in nonatopic asthma.

Kraneveld AD, van der Kleij HP, Kool M, van Houwelingen AH, Weitenberg AC, Redegeld FA, Nijkamp FP. Kraneveld AD, et al. Among authors: nijkamp fp. J Immunol. 2002 Aug 15;169(4):2044-53. doi: 10.4049/jimmunol.169.4.2044. J Immunol. 2002. PMID: 12165531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page